<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02921113</url>
  </required_header>
  <id_info>
    <org_study_id>09.2016.236</org_study_id>
    <nct_id>NCT02921113</nct_id>
  </id_info>
  <brief_title>suPAR in the Early Diagnosis of Acute Kidney Injury(AKI) After On-Pump Cardiac Surgery</brief_title>
  <official_title>Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Early Diagnosis of Acute Kidney Injury After On-Pump Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marmara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marmara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Kidney Injury(AKI) is of the serious complications in patients with undergoing on-pump
      cardiac surgery. End stage kidney failure requiring dialysis therapy after cardiac surgery is
      associated with more than 60% mortality rate. Involvement of AKI after on-pump cardiac
      surgery increases the mortality rate 19 times. suPAR is one of the novel biomarker which has
      potential prognostic value for renal dysfunction in patients with undergoing on-pump cardiac
      surgery. Early diagnosis and prompt intervention to prevent AKI has great importance for
      management of postoperative cardiac patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>2 days</time_frame>
    <description>Patients will be classified as AKI patients and non-AKI patients according to KDIGO classification. AKI patients will be subdivided into 3 subgroup according to KDIGO criteria.</description>
  </primary_outcome>
  <enrollment type="Actual">105</enrollment>
  <condition>Acute Kidney Injury</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma(suPAR) plasma(NGAL) urine NGAL serum creatinine plasma Cystatine C
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective on-pump cardiac surgery with no known kidney disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Approved informed concent Age higher than 18 years old

        Exclusion Criteria:

          -  Chronic kidney disease Renal transplantation Cancer history Previous cardiac surgery
             Sepsis Liver failure Thyroid dysfunction Having long term steroid therapy Having renal
             replacement therapy Exposure to nephrotoxic drug and radiocontrast substance before 5
             days of surgery Diagnosis of Acute Kidney Injury Intraaortic balloon or Extracorporeal
             Membrane Oxygenation insertion after surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bünyamin KIR, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University School of Medicine Dept of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>İsmail Cinel, Prof. M.D</last_name>
    <role>Study Director</role>
    <affiliation>Marmara University School of Medicine Dept of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beliz Bilgili, Asst. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University School of Medicine Dept. of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sinan Arsan, Prof. M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University School of Medicine Dept. of Cardiovascular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Marmara University School of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34890</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Khan E, Batuman V, Lertora JJ. Emergence of biomarkers in nephropharmacology. Biomark Med. 2010 Dec;4(6):805-14. doi: 10.2217/bmm.10.115. Review.</citation>
    <PMID>21133700</PMID>
  </reference>
  <results_reference>
    <citation>Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997 Feb 18;95(4):878-84.</citation>
    <PMID>9054745</PMID>
  </results_reference>
  <results_reference>
    <citation>Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Jul 31;17(8):952-60. doi: 10.1038/nm.2411.</citation>
    <PMID>21804539</PMID>
  </results_reference>
  <results_reference>
    <citation>Jalkanen V, Yang R, Linko R, Huhtala H, Okkonen M, Varpula T, Pettilä V, Tenhunen J; FINNALI Study Group. SuPAR and PAI-1 in critically ill, mechanically ventilated patients. Intensive Care Med. 2013 Mar;39(3):489-96. doi: 10.1007/s00134-012-2730-x. Epub 2012 Oct 26.</citation>
    <PMID>23100007</PMID>
  </results_reference>
  <results_reference>
    <citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12. Epub 2004 May 24. Review.</citation>
    <PMID>15312219</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2016</study_first_posted>
  <last_update_submitted>September 5, 2017</last_update_submitted>
  <last_update_submitted_qc>September 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suPAR</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>On-Pump Cardiac Surgery</keyword>
  <keyword>Biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

